Clinicopathological characteristics, surgical management, and outcomes of mammary Paget’s disease: 552 cases from a Japanese nationwide cancer registry

Purpose Mammary Paget’s disease (MPD) is a rare breast cancer characterized by the presence of Paget cells within the epidermis of the nipple–areolar complex. Traditionally, mastectomy has been the standard surgical treatment for MPD. However, outcomes following mastectomy and breast-conserving surgery (BCS) remain unclear. We investigated clinicopathological characteristics and survival outcomes of MPD using a Japanese nationwide registry. Methods Patients undergoing surgery for MPD between 2004 and 2018 were identified from the Japanese National Clinical Database–Breast Cancer Registry. We defined patients with an invasive component ≤ 1 mm (pTis/pT1mi), cN0, cM0 as “MPD-defined patients” based on the Japanese General Rules for Clinical and Pathological Recording of Breast Cancer. Clinicopathological characteristics were compared between the mastectomy and BCS groups. Disease-free survival (DFS) was evaluated using Kaplan–Meier analysis and a univariable Cox proportional hazards model. Results Among 552 MPD-defined patients, 541 had available surgical information (mastectomy, n = 388 ; BCS, n = 153). Twelve DFS events occurred. Local recurrence occurred in 2/388 patients (0.5%) after mastectomy and 3/153 patients (2.0%) after BCS. The 5-year DFS rates were 97.3% (95% confidence interval [CI], 94.9–98.6%) for mastectomy and 97.7% (95% CI, 93.0–99.3%) for BCS. The difference was not significant (log-rank p = 0.78). The unadjusted hazard ratio for BCS versus mastectomy was 1.20 (95% CI, 0.33–4.44). Conclusion MPD-defined patients showed favorable outcomes. No significant difference in DFS was observed between the mastectomy and BCS groups. BCS may be an acceptable treatment option for carefully selected patients with MPD.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11340304/v1
Primary Topic
Breast Lesions and Carcinomas
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Clinicopathological characteristics, surgical management, and outcomes of mammary Paget’s disease: 552 cases from a Japanese nationwide cancer registry

Tomoyuki Aruga, Hiraku Kumamaru, Naruto Taira, Toshiyuki Ishiba et al.
2 links
Research Square
Breast Lesions and Carcinomas
preprint

Clinicopathological characteristics, surgical management, and outcomes of mammary Paget’s disease: 552 cases from a Japanese nationwide cancer registry

Tomoyuki Aruga, Hiraku Kumamaru, Naruto Taira, Toshiyuki Ishiba, Naoko Kinukawa, Takaaki Konishi, Sakiko Maruya
preprint en

Abstract

Purpose Mammary Paget’s disease (MPD) is a rare breast cancer characterized by the presence of Paget cells within the epidermis of the nipple–areolar complex. Traditionally, mastectomy has been the standard surgical treatment for MPD. However, outcomes following mastectomy and breast-conserving surgery (BCS) remain unclear. We investigated clinicopathological characteristics and survival outcomes of MPD using a Japanese nationwide registry. Methods Patients undergoing surgery for MPD between 2004 and 2018 were identified from the Japanese National Clinical Database–Breast Cancer Registry. We defined patients with an invasive component ≤ 1 mm (pTis/pT1mi), cN0, cM0 as “MPD-defined patients” based on the Japanese General Rules for Clinical and Pathological Recording of Breast Cancer. Clinicopathological characteristics were compared between the mastectomy and BCS groups. Disease-free survival (DFS) was evaluated using Kaplan–Meier analysis and a univariable Cox proportional hazards model. Results Among 552 MPD-defined patients, 541 had available surgical information (mastectomy, n = 388 ; BCS, n = 153). Twelve DFS events occurred. Local recurrence occurred in 2/388 patients (0.5%) after mastectomy and 3/153 patients (2.0%) after BCS. The 5-year DFS rates were 97.3% (95% confidence interval [CI], 94.9–98.6%) for mastectomy and 97.7% (95% CI, 93.0–99.3%) for BCS. The difference was not significant (log-rank p = 0.78). The unadjusted hazard ratio for BCS versus mastectomy was 1.20 (95% CI, 0.33–4.44). Conclusion MPD-defined patients showed favorable outcomes. No significant difference in DFS was observed between the mastectomy and BCS groups. BCS may be an acceptable treatment option for carefully selected patients with MPD.

Research Square
Kawasaki Medical School (JP), Institute of Science Tokyo (JP), Yokohama City University (JP)
Good health and well-being
Breast Lesions and Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon